Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
Clinical trial NCT01951638 · COMPLETED
Trial details
- NCT number
- NCT01951638
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-06
- Primary completion
- 2015-08-18
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.